HER2 CAR-T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HER2 CAR-T cells, covering 2026-01-26 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases [Phase 1]